Skip to content

Evaluation of patients' satisfaction with the effectiveness of dopoxetin in premature ejaculation and its complications

Evaluation of patients' satisfaction with the effectiveness of dopoxetin in premature ejaculation and its complications

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200624047912N1
Enrollment
100
Registered
2020-07-07
Start date
2019-04-09
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature ejaculation. Premature ejaculation

Interventions

This study will be performed on patients with premature ejaculation in a semi-experimental manner. Dapoxetine 30 mg oral tablets are given by Kosar Pharmaceutical Company and Complete the questionnair

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Have ejaculatory ejaculation Be at least 20 to 40 years old Tendency to take medications regularly and continuously until the end of the treatment period Have a desire to participate and cooperate in this research 5. Have at least once a week close

Exclusion criteria

Exclusion criteria: Do not have any contraindications to the use of drugs (sensitivity to SSRI_ alcohol consumption_ calculation of lactose_ history of heart problem_depression) You have become _strength of safety_consumption of tramadol_ _MAOI Have no history of drug and alcohol use continuously Disorder of erection, genital urinary tract infection, systemic or neurological disorder, do not have severe mental disorder Do not have a history of IHD, DM, HTN, HLP and severe vascular disorders as proven

Design outcomes

Primary

MeasureTime frame
Ejaculation time. Timepoint: Before treatment - 10 days after treatment - one month later. Method of measurement: Questionnaires 1, 2 and 3whith Using a timer to minute.;Drug side effects. Timepoint: 10 days after treatment - one month later. Method of measurement: Questionnaires 2 and 3 mention the specified options.;Satisfaction with treatment. Timepoint: 10 days after treatment - one month later. Method of measurement: Questionnaires 2 and 3 mention excellent, good, medium, poor.

Secondary

MeasureTime frame
Ejaculation time score. Timepoint: Before treatment - 10 days after treatment - one month later. Method of measurement: Questionnaires 1, 2 and 3 with the option marked to the time score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Vahid Sadr Bolorian

Islamic Azad University

saeedtin.tavakolii@gmail.com+98 23 3236 3433

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026